The Parkinson's Disease Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Parkinson's Disease Market?
The Parkinson's Disease Global Market has experienced robust growth in recent years. The market size is projected to increase from $3.34 billion in 2024 to $3.63 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 8.5%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Parkinson's Disease Industry?
The Parkinson's Disease Global Market is projected to grow to $4.98 billion in 2029, with a compound annual growth rate (CAGR) of 8.2%.
Download Your Free Sample of the 2025 Parkinson's Disease Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Parkinson's Disease Market?
The key drivers in the parkinson's disease market are:
• Growing awareness regarding Parkinson's disease symptoms
• Rise in government initiatives aimed at combatting Parkinson's Disease
• Increase in healthcare spending dedicated to Parkinson's disease
• Increasing adoption of gene therapy treatments for Parkinson's disease
Global Market Segmentation: Identifying Major Parkinson's Disease Industry Segments
The parkinson's disease market covered in this report is segmented –
1) By Drug Class: Dopamine Agonists, Catechol-O-Methyltransferase Inhibitors, Monoamine Oxidase B Inhibitors, Anticholinergics, Carbidopa-Levodopa, Other Drug Classes
2) By Route Of Administration: Oral, Injectable, Intestinal infusion, Subcutaneous, Other Route Of Administrations
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies
4) By Patient Care Setting: Clinics, Hospitals
Subsegments:
1) By Dopamine Agonists: Ergot Derivatives, Non-Ergot Derivatives
2) By Catechol-O-Methyltransferase (COMT) Inhibitors: Entacapone, Tolcapone, Opicapone
3) By Monoamine Oxidase B (MAO-B) Inhibitors: Selegiline, Rasagiline, Safinamide
4) By Anticholinergics: Trihexyphenidyl, Benztropine, Procyclidine
5) By Carbidopa-Levodopa: Immediate-Release Formulation, Extended-Release Formulation, Inhaled And Intestinal Gel Formulations
6) By Other Drug Classes: Amantadine And Derivatives, Adenosine A2A Receptor Antagonists, Glutamate Antagonists
Pre-order the 2025 Parkinson's Disease Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Parkinson's Disease Market?
The key trends in the parkinson's disease market are:
• There is a trend toward leveraging technology advancements in the Parkinson's disease market.
• Increased funding and initiatives provided by governments are shaping the global landscape.
• The application of artificial intelligence in disease diagnosis is an emerging trend.
• A move towards innovative solutions and personalized medicine is gaining traction in the market.
Who Are the Top Competitors & Leading Players in the Parkinson's Disease Market?
Major players in the parkinson's disease market are:
• Roche Holding AG
• AbbVie Inc.
• Novo Nordisk A/S
• Takeda Pharmaceutical Company Limited
• UCB S.A.
• Eisai Co. Ltd.
• Kyowa Kirin Co. Ltd.
• Amneal Pharmaceuticals Inc.
• Neurocrine Biosciences Inc.
• Supernus Pharmaceuticals Inc.
• Sunovion Pharmaceuticals Inc.
• Intracellular Therapies Inc.
• Voyager Therapeutics Inc.
• Sage Therapeutics Inc.
• Adamas Pharmaceuticals Inc.
• Sun Pharma Advanced Research Company Ltd.
• Neuraly Inc.
• Mitsubishi Tanabe Pharma Corporation
• Athira Pharma Inc.
• VistaGen Therapeutics Inc.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the parkinson's disease market in 2024
